Digital Polymerase Chain Reaction Market (dPCR): 26% CAGR Forecast Globally to 2019

DALLAS, February 5, 2015 /PRNewswire/ --

ReportsnReports.com adds Global Digital PCR (dPCR) Market 2015-2019 research report of 73 pages that forecasts the dPCR industry to grow at a CAGR of 26.45% during 2014 to 2019, across the globe.

The Digital PCR (dPCR) Market report emphasizes advances in dPCR technologies and instruments such as improvements in system design that provide a high degree of accuracy and efficiency in sample processing and data analysis. The innovations in Digital PCR instruments and software help analyze and manage a huge amount of data and provide better quality results.

Analysts forecast the Global Digital PCR market to grow at a CAGR of 26.45% over the period 2014-2019. Digital polymerase chain reaction (dPCR) technology provides a higher degree of accuracy and reproducibility in the amplification and analysis of nucleic acids like DNA, RNA and cDNA, than any other PCR technology. Droplet digital polymerase chain reaction (ddPCR), a new and advanced technology, offers complete quantification of target DNA molecules with a high degree of accuracy, precision and sensitivity for quantitative PCR applications.

Advanced dPCR (Digital PCR) technology provides higher accuracy and reproducibility than traditional PCR technology in the amplification and analysis of nucleic acids. The Digital PCR technology is an innovative PCR that allows amplification and directs quantification of nucleic acids such as DNA, RNA, cDNA, and methylated DNA with high precision. The Digital PCR technology is not dependent on the number of amplification cycles to quantify the initial sample amount and provides absolute quantification of nucleic acids. dPCR can analyze a small amount of sample and provide higher accuracy, precision, and efficiency than the conventional PCR technology.

The report covers the present scenario and the growth prospects of the Global Digital PCR market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of dPCR products: dPCR consumables, and dPCR instruments.

The "Global Digital PCR (dPCR) Market 2015-2019" report recognizes the following companies as the key players in the Global Digital PCR (dPCR) Market Bio-Rad Laboratories, Fluidigm, RainDance Technologies and Thermo Fisher Scientific.

Other Prominent Vendors in the market are Abbott Laboratories, Affymetrix, Analytik Jena, ArcticZymes, Becton Dickinson, Bibby Scientific, bioMerieux, Biosearch Technologies, BIOTECON Diagnostics, Eppendorf, Exiqon, Formulatrix, Illumina, Integrated DNA Technologies, Promega, Sigma-Aldrich, Stilla Technologies

Order a copy of this report at (Prices start at US $ 2500 for a single user PDF) http://www.reportsnreports.com/Purchase.aspx?name=344025  .

The Digital PCR technologies have a broad range of applications in various fields including - Drug discovery and development, Clinical diagnostics, Research and Others.

Global dPCR Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC region, and the EMEA region; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Another report on Polymerase Chain Reaction "Global qPCR and dPCR Market 2015-2019" (http://www.reportsnreports.com/reports/323209-global-qpcr-and-dpcr-market-2015-2019.html ) says that advances in the technology of qPCR and dPCR are one of the major drivers of the market. As a result of automation, and improved accuracy and sensitivity, the popularity of qPCR and dPCR technologies and products has increased. Advanced qPCR and dPCR products provide a high level of efficiency and productivity in research and drug discovery, and this helps reduce the time required for the development of new drugs.

Analysts forecast the Global qPCR and dPCR market to grow at a CAGR of 9.67% over the period 2014-2019. The increased adoption of dPCR technology is one key trend emerging in the market. Advanced dPCR technology and products provide a high level of accuracy and productivity in research and drug discovery, and reduce the consumption of reagents.

Order a copy of this report at (Prices start at US $ 2500 for a single user PDF) http://www.reportsnreports.com/Purchase.aspx?name=323209  /

The Global qPCR and dPCR Market 2015-2019 report recognizes the following companies as the key players in the Global qPCR and dPCR Market: Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Qiagen N.V. and Thermo Fisher Scientific Inc.

Other Prominent Vendors in the market are: Advanced Molecular Systems, Affymetrix, altona Diagnostics, Anachem, Analytik Jena, ArcticZymes, Becton Dickinson, Bibby Scientific, bioMerieux, Biosearch Technologies, BIOTECON Diagnostics, Biotools B&M Labs, Central Biotechnology Services, Cepheid, Eppendorf, Eurogentec (a part of Kaneka Corporation), Exiqon, Fast-track Diagnostics, Fluidigm, Fluorogenics, Formulatrix, Harvard Bioscience, Illumina, Integrated DNA Technologies, Integromics, Kapa Biosystems, Kyratec, Ocimum Biosolutions, Optigene, PCR Biosystems, PerkinElmer, Primerdesign, Promega, RainDance Technologies, Sacace Biotechnologies, Takaro Bio, TATAA Biocenter, Tecan, WaferGen Biosystems and Quidel.

qPCR (Real-time Polymerase Chain Reaction) and dPCR (Digital Polymerase Chain Reaction) are the advanced PCR technologies that provide higher accuracy and reproducibility in nucleic acids amplification and analysis. qPCR allows amplification and quantification of a targeted DNA molecule in real-time. While dPCR is an advanced PCR that allows direct quantification and amplification of nucleic acids including RNA, DNA, cDNA, methylated DNA. It does not rely on the number of amplification cycles to measure the initial sample amount and provides absolute quantification of nucleic acid. qPCR and dPCR need a small amount of sample and provide higher accuracy, sensitivity, and efficiency than conventional PCR.

Further, the report states that intense competition among vendors is one of the major challenges that the market faces. Companies are increasingly investing in R&D to improve their existing product portfolio and to design new products. The presence of many vendors with extensive product portfolios is resulting in the reduction of the profit margins of these companies.

Browse other reports on Biotechnology Market at http://www.reportsnreports.com/market-research/biotechnology/  .

About Us:
ReportsnReports.com is an online market research reports library of 500,000+ reports and in-depth studies of 5000+ micro markets. We provide reports by 100+ publishers on a range of categories and industries.

Connect with Us:

G+ / Google Plus:https://plus.google.com/u/0/111656568937629536321/posts

Twitter:http://twitter.com/marketsreports

Facebook:https://www.facebook.com/pages/ReportsnReports/191441427571689

RSS / Feeds:http://www.reportsnreports.com/feed/l-latestreports.xml

Contact:  

Ritesh Tiwari

TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252

Tel: +1-888-391-5441

[email protected]

SOURCE ReportsnReports